tm logo

Monitor this mark

View On USPTO

ASTAGRAF XL
Live/Registered
REGISTERED AND RENEWED

on 23 Jul 2024

Last Applicant/ Owned by

Astellas Pharma Inc.

5-1, Nihonbashi-Honcho 2-chome

Chuo-ku, Tokyo

JP

103-8411

Serial Number

85925271 filed on 07th May 2013

Registration Number

4480263 registered on 11th Feb 2014

in the Principal Register

Correspondent Address

David J. Davis

David J. Davis BAKER & MCKENZIE LLP

SUITE 5000

CHICAGO, IL 60601

United States

Filing Basis

No Filing Basis

Disclaimer

NO DATA

ASTAGRAF XL

Pharmaceuticals, namely, immunotherapy preparations

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceuticals, namely, immunotherapy preparations

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 85925271

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 51170757

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
23rd Jul 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
23rd Jul 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
23rd Jul 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
22nd Jul 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09th Jul 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Jul 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09th Jul 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09th Jul 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09th Jul 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07th May 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9